ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ANCR Animalcare Group Plc

211.00
-3.00 (-1.40%)
18 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Animalcare Group Plc LSE:ANCR London Ordinary Share GB0032350695 ORD 20P
  Price Change % Change Share Price Shares Traded Last Trade
  -3.00 -1.40% 211.00 8,457 10:20:46
Bid Price Offer Price High Price Low Price Open Price
202.00 220.00 214.00 209.00 214.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Veterinary Service-livestock 71.62M 1.97M 0.0327 64.53 126.81M
Last Trade Time Trade Type Trade Size Trade Price Currency
14:12:15 O 12 205.00 GBX

Animalcare (ANCR) Latest News

Animalcare (ANCR) Discussions and Chat

Animalcare Forums and Chat

Date Time Title Posts
17/3/202416:14Animalcare : contrarian value opportunity ?50
06/3/201920:37ANIMALCARE GROUP/Ritchey132

Add a New Thread

Animalcare (ANCR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2024-03-18 14:12:16205.001224.60O
2024-03-18 11:00:05208.009992,077.92UT
2024-03-18 10:46:13209.904,2008,815.80O
2024-03-18 10:20:34210.002,0404,284.00O
2024-03-18 10:00:10210.00450945.00O

Animalcare (ANCR) Top Chat Posts

Top Posts
Posted at 18/3/2024 08:20 by Animalcare Daily Update
Animalcare Group Plc is listed in the Veterinary Service-livestock sector of the London Stock Exchange with ticker ANCR. The last closing price for Animalcare was 214p.
Animalcare currently has 60,097,623 shares in issue. The market capitalisation of Animalcare is £126,805,985.
Animalcare has a price to earnings ratio (PE ratio) of 64.53.
This morning ANCR shares opened at 214p
Posted at 16/3/2024 08:58 by masurenguy
Looks like they got a very good price (£24.9m) for Identicare (annual sales just circa £3m) and the disposal has also enabled them to restructure the balance sheet with a post completition net cash position of circa £27m. Would doubt that the CMA investigation would have any significant concerns for them since the issue relates to Vet mark up margins rather than ANCR wholesale prices. This company seems to be under most retail investors radar screens but circa 70% of the shares are owned by around half a dozen institutions so this looks worth further research and investigation.
Posted at 13/3/2024 16:17 by 1c3479z
have to agree that ANCR least likely to be affected by the CMA enquiry, just putting it out as a conjecture, if the whole vet industry is to be brought to heal by the authorities. Not trying to scare at all as ANCR is a family holding, albeit small, sadly, in comparison with my own holding in CVSG which is much more in the firing line.
Posted at 13/3/2024 14:34 by wjccghcc
No. The CMA was complaining that some vets add a big mark up on the wholesale price vs the internet pharmacies.
Posted at 13/3/2024 13:22 by 1c3479z
CMA mounting a big enquiry, will that impact the price of veterinary drugs in general including wholesale?
Posted at 26/11/2021 12:55 by km18
From WealthOracleAM....

Animalcare Limited founded in 1988 became the Animalcare Group in 2008. In July 2017 they made a reverse acquisition of Ecuphar NV, which is still casting a shadow over the share, as the share remains belowthe price before the transaction. Currently they are operating in 32 markets through 220 employees. ANCR is adopting a more organic approach towards growth, with focus on key therapy areas and new products development. This can be seen also in the financials with goodwill relatively flat over the years, but at quite high percentage of total assets – 51%, which has been impaired recently.
Other than the “underappreciated” by investors investment in 2017, the Group has been performing rather well. They have reduced their debt and increasing the cash generated from operations, thus gearing is minuscule at 16%. Revenue is growing at 39.1% CAGR, ROCE at 4.52% and dividends were doubled in 2020 from 2019, so there is plenty of return for the investors. However, ANCR remains very highly priced, with P/S just below the industry average and EV/EBITDA being quite high at 25.09.
Posted at 08/7/2021 14:09 by wjccghcc
It is 23% of the company and the placing price is where the share price was 6 weeks ago so the discount is not that surprising.

It’s clear that Cardon has been wanting to move onto other things since he gave up being CEO in 2018 and then moved to non exec in 2019.

At least the overhang is gone now.
Posted at 08/7/2021 13:28 by pugugly
Secondary placing - Hit share price very hard. Views?
8 July 2021. Animalcare Group plc (AIM: ANCR), the international animal health business, announces that it has been notified by Ecuphar Invest NV ("Seller") of its intention to sell up to 13,857,213 ordinary shares in the capital of the Company (the "Placing" and the "Placing Shares") at a price of 285 pence per Placing Share ("Placing Price"). The Placing Price represents a c. 20 per cent. discount to the closing price of 356 pence per share on 7 July 2021
Posted at 10/6/2021 14:47 by trcml
Nice uplift since I bought during the first week of May. Our vet uses ANCR products:when i mentioned the imminent release of a new product, the vet was very interested . Suppliers of products to vets are onto a good thing.
Posted at 21/1/2021 14:39 by bunz3
that video now on ggp share board , a good example for other shares
Posted at 21/12/2020 10:25 by energeticbacker
The growth in pet ownership over lockdown and owner’s desires to keep their pets fit and healthy has been great news for the pet care sector. However, who are going to be the long-term winners from the current pet boom?

Investor’s Champion’s research highlights some terrific companies which should continue to do well, including a star performer. #ancr #chwy #cvsg #elan #idxx #nesn #pets #zts
Animalcare share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com